Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosis of Neuroendocrine Neoplasms and Assessment of Response to Surgery by Means of Measurement of Gene Transcripts in Blood

NCT03012789 is registered in ClinicalTrials.gov with Wren Laboratories LLC as lead sponsor.

NCT NCT03012789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03012789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosis of Neuroendocrine Neoplasms and Assessment of Response to Surgery by Means of Measurement of Gene Transcripts in Blood
Lead sponsor
Wren Laboratories LLC
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
June 1, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteropancreatic, neuroendocrine tumor